DeNovo
339 East 3900 South Suite 155, Salt Lake City, Utah, 84107
Service Settings
- OP Outpatient
- OD Outpatient detoxification
- OMB Outpatient methadone/buprenorphine or naltrexone treatment
- ORT Regular outpatient treatment
Facility Operation
- PVTP Private for-profit organization
Treatment Approaches
- ANG Anger management
- CBT Cognitive behavioral therapy
- MOTI Motivational interviewing
- RELP Relapse prevention
- SACA Substance use counseling approach
- TELE Telemedicine/telehealth therapy
- TRC Trauma-related counseling
- TWFA 12-step facilitation
Type Of Care
- SA Substance use treatment
- DT Detoxification
- SUMH Treatment for co-occurring serious mental health illness/serious emotional disturbance and substance use disorders
Payment Accepted
- FSA Federal
- MC Medicare
- MD Medicaid
- PI Private health insurance
- SF Cash or self-payment
License/ Certification/ Accreditation
- STAG State substance abuse agency
- STMH State mental health department
- CARF Commission on Accreditation of Rehabilitation Facilities
- SOTP SAMHSA certification for opioid treatment program (OTP)
- DEA Drug Enforcement Agency (DEA)
Facility Smoking Policy
- SMPD Smoking permitted in designated area
Special Programs
- WN Adult women
- MN Adult men
- CO Clients with co-occurring mental and substance use disorders
Opioid Medications Used In Treatment
- MU Methadone used in Treatment
- BU Buprenorphine used in Treatment
- NU Naltrexone used in Treatment
Type Of Alcohol Use Disorder Treatment
- PMAT This facility administers/prescribes medication for alcohol use disorder
Facility Vaping Policy
- VPPD Vaping permitted in designated area
Type Of Opioid Treatment
- DB Buprenorphine detoxification
- BUM Buprenorphine maintenance
- OTP SAMHSA-certified Opioid Treatment Program
- DM Methadone detoxification
- MM Methadone maintenance
- UB Prescribes buprenorphine
- UN Administers naltrexone
- RPN Relapse prevention from naltrexone
- DLC Lofexidine or Clonidine detoxification
- MWS Maintenance service with medically supervised withdrawal after stabilization
External Source Of Medications Used For Alcohol
- AUINPE In-network prescribing entity
Pharmacotherapies
- ACM Acamprosate (Campral)
- DSF Disulfiram
- METH Methadone
- BSDM Buprenorphine sub-dermal implant
- BWN Buprenorphine with naloxone
- BWON Buprenorphine without naloxone
- BERI Buprenorphine (extended-release)
- NXN Naltrexone (oral)
- VTRL Naltrexone (extended-release)
- LFXD Lofexidine
- CLND Clonidine
- MMD Medication for mental disorders
- NRT Nicotine replacement
- NSC Non-nicotine smoking/tobacco cessation
Assessment/Pre Treatment
- CMHA Comprehensive mental health assessment
- CSAA Comprehensive substance use assessment
- ISC Interim services for clients
- OPC Outreach to persons in the community
- MHPA Complete medical history/physical exam
- STU Screening for tobacco use
- SSA Screening for substance use
- SMHD Screening for mental disorders
- PIEC Professional interventionist/educational consultant
Testing
- BABA Breathalyzer or blood alcohol testing
- DAUT Drug or alcohol urine screening
- STDT STD testing
- TBS TB screening
Age Groups Accepted
- YAD Young adults
- ADLT Adults
Recovery Support Services
- HS Housing services
- AOSS Assistance with obtaining social services
- EMP Employment counseling or training
Transitional Services
- ACC Aftercare/continuing care
- DP Discharge Planning
- NOE Naloxone and overdose education
- OFD Outcome follow-up after discharge
Detoxification (medical Withdrawal) Services
- ODTX Opioid Detoxification
- MDET Medication routinely used during detoxification
Other Services
- TOD Treatment for other addiction disorder
Education And Counseling Services
- HAEC HIV or AIDS education
- TAEC Hepatitis education
- HEOH Health education services other than HIV/AIDS or hepatitis
- SAE Substance use disorder education
- ICO Individual
- GCO Group
- FCO Family
- MCO Marital/couples
Ancillary Services
- CM Case management service
- MHS Mental health services
- SSD Social skills development
- SPS Suicide prevention services
